16 × AIAI signal, amplified
AI newsAboutSources
TelegramFollow on Telegram
AI newsAboutSources
16 × AIAI signal, amplified

An AI news engine that ingests trusted sources, scores with Claude, and posts only what clears the bar.

Follow on Telegram →

Subscribe

  • Telegram
  • RSS
  • All channels

Legal

  • Privacy
  • Imprint
© 2026 16 × AI. All rights reserved.Curated by Claude. Posts every 6 hours. No newsletter, no funnel.
Home/Market & Regulation
Market & Regulation

OpenAI Enhances ChatGPT Enterprise Controls

OpenAI·June 18, 2026·high confidence

Why it matters

  • →Provides enterprises with better cost management tools for AI usage.
  • →Enhances transparency and predictability in AI-related expenses.
  • →Offers insights into AI utilization, aiding in workflow optimization.

OpenAI has introduced new spend controls and usage analytics for its ChatGPT Enterprise product. These features are designed to help organizations manage their AI-related expenses more effectively and scale their AI usage with confidence. The spend controls allow for better cost predictability, while the usage analytics provide insights into how AI is being utilized within the organization. This development is part of OpenAI's efforts to enhance the usability and financial transparency of its AI solutions for enterprise clients.

Read original

More from OpenAI

Models & Labsmodels

ChatGPT Enhances Health Intelligence with GPT-5.5

OpenAI's latest update to ChatGPT, powered by GPT-5.5 Instant, marks a significant step forward in health and wellness communication. By integrating stronger reasoning capabilities and physician-informed evaluations, the model aims to provide clearer and more contextually accurate responses. This enhancement is particularly relevant for users seeking reliable health information, as it promises to improve the quality of advice and insights offered. While not a substitute for professional medical advice, this update positions ChatGPT as a more informed digital assistant in the health domain.

OpenAI·Jun 18, 2026
Researchresearch

AI Model Aids in Diagnosing Rare Genetic Diseases

AI is making significant inroads in the medical field by assisting physicians in diagnosing rare genetic diseases in children. Researchers have successfully used an OpenAI reasoning model to uncover 18 new diagnoses in cases that had previously defied resolution. This breakthrough demonstrates the potential of AI to improve diagnostic accuracy and speed, especially in complex scenarios where traditional methods are inadequate. By incorporating AI into medical diagnostics, healthcare professionals can potentially enhance outcomes for patients with rare conditions, offering new possibilities where there were few before.

OpenAI·Jun 18, 2026

More in Market & Regulation

U.S. Restricts Anthropic's AI Models Over Security Concerns© TechCrunch AI
Market & Regulationbusiness

U.S. Restricts Anthropic's AI Models Over Security Concerns

The U.S. government has imposed export controls on Anthropic's AI models, Fable and Mythos, citing national security concerns. This move marks a significant test of whether such controls can effectively contain advanced AI technologies, reminiscent of past efforts with encryption and spyware. Anthropic's models were initially restricted to a select group of vetted users, but recent events involving a South Korean telecom and Amazon's security concerns prompted the ban. The outcome of this situation could influence future regulations for AI labs and their access to international markets.

TechCrunch AI·Jun 19, 2026
Amazon to Sell Trainium Chips to Third-Parties© Lev Selector
Market & Regulationbusiness

Amazon to Sell Trainium Chips to Third-Parties

Amazon will begin selling its Trainium chips to third-party companies, expanding its hardware offerings.

Lev Selector·Jun 19, 2026
SpaceX Acquires Cursor for $60 Billion© Lev Selector
Market & Regulationbusiness

SpaceX Acquires Cursor for $60 Billion

SpaceX has acquired Cursor for $60 billion, expanding its technological capabilities.

Lev Selector·Jun 19, 2026